About My Health Careers Internship MedBlogs Contact us
Blood Transfusion during Liver Cancer Surgery may Lead to Recurrence of Cancer and Death

Blood Transfusion During Liver Cancer Surgery May Lead to Recurrence of Cancer and Death

Font : A-A+

  • Blood transfusion during liver cancer surgery may lead to the recurrence of cancer and premature death
  • More randomized trials are required to assess the influence of blood transfusion on cancer outcomes
  • Surgeons should also focus on practices that would reduce the need for transfusion

Cancer affecting the liver is called hepatocellular carcinoma and is the most common type of malignancy that affects the liver. The surgery to remove such cancer is complex and invariably requires a blood transfusion. According to new research, any such transfusion may be associated with a higher risk of cancer recurrence and premature death.

Hepatocellular Carcinoma (HCC) and its Treatment

HCC is the fifth most common form of cancer and the third most common cause of cancer-related deaths worldwide. People with cirrhosis, which is scarring of the liver caused by earlier damages from hepatitis B or C virus, or long-term alcohol abuse, have the risk of being affected with HCC.


Blood Transfusion During Liver Cancer Surgery May Lead to Recurrence of Cancer and Death

Liver resection, a surgical procedure that removes cancer and a margin of healthy tissue that surrounds it is used to treat patients with early-stage liver cancer, having a normal liver function. Despite advances made in liver surgery that have helped reduce the surgical blood loss considerably, liver resection is associated with the risk of excessive blood loss and requirement of blood transfusion.

Blood Transfusion and Cancer Outcomes

The magnitude of the effect of blood transfusions on cancer outcomes has never been understood completely. Research on this subject has reported conflicting findings for decades now. It has not been possible to arrive upon a conclusion if the problems are caused by blood transfusion alone.

There was a noticeable increase in risk even when a small amount of blood was transfused, the researchers of the study have reported. The study findings have shown that cancer recurrence risk increased by 23 percent and death by 55 percent following transfusion of 1 to 4 units of blood, when compared to matched controls.

Dr Ying-Hsuan Tai from Taipei Medical University Shuang Ho Hospital in Taiwan, the study's lead researcher remarked, "Our findings from a large cohort highlighted a significant association between red blood cell transfusions and the risk of cancer recurrence as well as a dose-response relationship between the amount of transfusions and death after curative surgery for liver cancer. The reason why blood transfusions substantially worsen cancer prognosis remains unclear, but it is likely to be related to the suppressive effects on the immune system,"

Study Design and Results

The effect of perioperative blood transfusion on cancer prognosis in 1,469 patients who had undergone HCC resection surgery at Taipei Veterans General Hospital, Taipei, Taiwan between 2005 and 2016 was studied by Dr. Tai and his team. There was no lymph node involvement or metastasis in these patients. Postoperative disease-free survival and overall survival up to September 2018 were assessed by the team.

While comparing patient outcomes, inverse probability of treatment weighting, a statistical modeling technique was used to match patients who had equivalent age and health conditions.

1 to 4 units of allogeneic blood were given to 1 in 3 patients (30 percent; 447 patients), during or within 7 days of surgery, while more than 4 units were given to more than 1 in 10 patients (12 percent; 179 patients). In a median 45 month follow-up, investigations showed that there was a 23 percent chance of cancer recurrence in patients who received a transfusion (1-4 units) as compared to those who did not. Similarly, patients who received more than 4 units were faced with an 18 percent greater risk of recurrence when compared to those who did not receive any.

Patients who received 1-4 units of blood were 55 percent more likely to die from any cause in comparison to those who did not receive a transfusion. Those who received 4 or more units had almost double the risk of death.

The authors of the study concluded, "These data highlight the need for randomized trials to evaluate the influence of transfusion on cancer outcome and identify the level anemia that patients undergoing liver cancer surgery can withstand (or the minimum amount of blood they need to have transfused) with minimal adverse effects in order to guide practice. Until these trials have been completed, surgeons should use practices that reduce the risk of bleeding and the need for transfusion."

The findings of the study will be presented at the Euro-anaesthesia Congress, the annual meeting of the European Society of Anaesthesiology to be held this year at Vienna, Austria.

Reference :
  1. European Society of Anaesthesiology - (https://www.esahq.org/)

Source: Medindia

News A-Z
News Category
What's New on Medindia
Goji Berries May Protect Against Age-Related Vision Loss
Tapping — A Proven Self-Applied Stress Intervention
Black Pepper as Preventive Measure Against Omicron
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Alcoholic Liver Disease Hepatitis A Hepatitis B Thalassemia Liver Cancer Cancer and Homeopathy Neonatal Jaundice Bubbles and Brews - Alcohol Facts Cancer Facts Death Facts 

Recommended Reading
Current Treatments for Liver Cancer
Current Treatments for Liver Cancer (also known as hepatoma or hepatocellular carcinoma) can result ...
Blood Transfusion - Frequently Asked Questions
This section lists out some questions that a patient normally asks a doctor....
Liver Cancer Treatment - Animation
Liver Cancer is the uncontrolled growth of cells in the liver. The present section provides a ......
Alcoholic Liver Disease
Encyclopedia section of medindia gives general information about Alcoholic Liver Disease....
Bubbles and Brews - Alcohol Facts
There is more to alcohol than mere intoxication. Infamous because of its social abuse but indispensa...
Hepatitis A
Hepatitis A is the most benign of the hepatitis viruses and usually has no long term side effects. H...
Hepatitis B
Hepatitis B is inflammation of the liver due to infection with the hepatitis B virus....
Liver Cancer
Liver or hepatic cancer is an abnormal growth of cells in the liver. The leading cause of the diseas...
Neonatal Jaundice
Yellow colouring of skin in newborns, a condition called Neonatal jaundice. , Neonatal jaundice is c...
Thalassemia is an inherited blood disorder passed on through parental genes causing the body to prod...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)